Mumbai (Maharashtra) [India], February 12: Marking the Low Vision awareness month of February, RevitalVision announced the expansion of their team in India as part of their commitment to make their US FDA-cleared vision-training software program available to maximum eye specialists in India
Rishikesh (Uttarakhand) [India], February 3: More and more yoga practitioners seem to be interested in completing a 200 hour yoga Teacher Training in India for various reasons. Gyan Yog Breath, one of the most renowned yoga institutes in India, has been a primary destination for internationa
Researchers at Osaka University have developed a new therapy technique for cytokine storm, a devastating inflammatory disease caused by an infection or severe burn.
Mumbai (Maharashtra) [India], January 17: As India grapples with a diabetes epidemic, Fitterfly, a leading ISO-13485 certified digital therapeutics company with clinically-proven programs, releases its comprehensive report, 'Reimagining Diabetes Care 2024'. This study showcases the data from
Mumbai (Maharashtra)/ Hyderabad (Telangana) [India], January 9: GlobalSpace Technologies Limited unveiled GoRoga, India's first Anti-Stress wearable under the Make in India initiative. The inaugural event, held at Chancellor Hall, NSCI Club, Worli, Mumbai on 4th January 2024 was jointly pres
Pune (Maharashtra) [India], December 29: Respiratory illnesses constitute a significant threat to health, affecting individuals across all age groups and standing as common causes of morbidity and mortality. The intricate nature of these disorders necessitates specialised training for health
Ahmedabad (Gujarat) [India], December 20: Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma) for a biosimilar
Much research has been undertaken over many decades on diseases that affect large populations, such as cancer and heart disease. Therapeutic approaches have considerably improved as a result of long-term research work on diseases that affect a huge number of individuals.
Over many decades, much study has been conducted on diseases that affect big populations, such as cancer and heart disease. As a result of long-term research efforts on diseases that affect a large number of people, therapeutic approaches have vastly improved.
Researchers have discovered a new therapeutic target for pulmonary hypertension, a type of high blood pressure that affects the blood vessels in the lungs.
According to a report, projections indicate a substantial surge in revenues from USD 2.65 billion in 2023 to an impressive USD 9.65 billion by 2028, with an anticipated annual growth rate of 29.50 per cent.
A recent review article Therapy summarises major milestones in the development of gene therapy medical products that have aided in the treatment of a large number of uncommon disorders. The essay also discusses the obstacles to the advancement of gene therapy for rare disorders.